We are live on
!
Find out more
CNTA
Centessa Pharmaceuticals
CNTA
CNTA
125 hedge funds and large institutions have $3.11B invested in Centessa Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 53 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 117 → 125 (+8)
3.31% more ownership
Funds ownership: 92.52% → 95.83% (+3.3%)
42% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 53
Holders
125
Holding in Top 10
11
Calls
$33.2M
Puts
$22.6M
Top Buyers
| 1 | +$103M | |
| 2 | +$43.6M | |
| 3 | +$34.7M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$31.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$29M |
Top Sellers
| 1 | -$27M | |
| 2 | -$20M | |
| 3 | -$19.6M | |
| 4 |
Millennium Management
New York
|
-$13.4M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$13.1M |